SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-18-010941
Filing Date
2018-08-09
Accepted
2018-08-09 16:11:35
Documents
7
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 6-K 2Q 2018 REPORT q2-2018x6k1.htm 6-K 22005
2 EXHIBIT 99.1 - 2Q 2018 FINANCIALS q2-2018xex991fsxquarterly1.htm EX-99.1 815405
3 EXHIBIT 99.2 - 2Q 2018 MD&A q2-2018xex992mdaxquarterly1.htm EX-99.2 375235
4 EXHIBIT 99.3 CEO CERT 2Q 2018 q2-2018xex993certification.htm EX-99.3 12607
5 EXHIBIT 99.4 CFO CERT 2Q 2018 q2-2018xex994certification.htm EX-99.4 12576
6 AEZS LOGO aeternazentarislogoa86.jpg GRAPHIC 14150
7 OS outsourcea04.jpg GRAPHIC 57688
  Complete submission text file 0001628280-18-010941.txt   1338199
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 181005141
SIC: 2834 Pharmaceutical Preparations